Neurodegenerative mechanisms in Christianson syndrome and NHE6-related disorders
Christianson 综合征和 NHE6 相关疾病的神经退行性机制
基本信息
- 批准号:10020810
- 负责人:
- 金额:$ 94.82万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2019
- 资助国家:美国
- 起止时间:2019-09-15 至 2024-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAdultAgingAllyAlzheimer&aposs DiseaseAlzheimer&aposs disease related dementiaAxonal TransportBiochemicalBrainCellsCellular biologyCerebellar degenerationChristianson syndrome CollectionCommunitiesDataDefectDevelopmentDevelopmental Delay DisordersDiffuseDiseaseEarly EndosomeEndosomesEpilepsyExhibitsExonsExperimental ModelsFemaleFunctional disorderGTPase-Activating ProteinsGenesGenetic DiseasesHumanHuman GeneticsImpairmentIn VitroInternationalLaboratoriesLeadLightingLinkLysosomesMediatingMicroscopyModelingMusMutationNatural HistoryNerve DegenerationNeurodegenerative DisordersNeuronsPathologicPathologyPatientsPhenotypePopulationPositioning AttributePublic HealthPublishingRattusResearchResolutionResourcesRoleSiteSorting - Cell MovementSpeedStructureSynapsesSyndromeSystemTechniquesTestingTissuesToxic effectX Inactivationage relatedaxonal degenerationconditional mutantexosomeexperimental studyin vivoin vivo Modelinduced pluripotent stem cellinnovationinsightlate endosomeloss of function mutationmalemutantmutation carriernervous system disordernew therapeutic targetnovel therapeuticspatient oriented researchpatient registryprogressive neurodegenerationproteostasistau Proteinstau mutationtissue mosaicismtooltranslational approachtranslational neuroscience
项目摘要
PROJECT SUMMARY
Human genetics offers a powerful approach to dissect cellular mechanisms in neurodegenerative disease. We
are studying new genetic conditions with neurodegeneration caused by mutations in the X-linked endosomal
Na+/H+ exchanger 6 (NHE6, also known as SLC9A6). Dysfunction of the endolysosomal system is a common
feature in many neurodegenerative disorders. Loss-of-function mutations in NHE6 in males cause Christianson
syndrome (CS), which displays mixed neurodevelopmental and neurodegenerative pathology. My research
group has recently discovered adult-onset, neurodegenerative disease in female NHE6 mutation carriers. Data
in NHE6-related disease support pathology, including axonal degeneration, cerebellar degeneration, and
diffuse tau-related disease. The objective of the research in this R01 proposal is to define the cellular
mechanisms that cause NHE6-related neurodegeneration, as well as to develop mechanistic linkages to other
related neurodegenerative disorders, including Alzheimer’s disease (AD) and AD-related dementias (ADRD).
Our central hypothesis is that loss of NHE6 leads to abnormal maturation of late endosomes, thereby causing
aberrant retrograde axonal transport and lysosomal dysfunction. My research group, with our collaborators, is
in an excellent position to study NHE6-related neurologic disease, both in males and females, as we have
developed unique resources including: an international patient registry with patient phenotypic information; the
mouse Nhe6 conditional mutant; a panel of patient-derived iPSC cells with robust controls; and an Nhe6-null
rat model. We capitalize on the relative strengths of each experimental model to address our scientific
questions. We will pursue the following Specific Aims: 1) Demonstrate that neuronal, cell-autonomous loss of
NHE6 function in the mature brain causes neurodegeneration; 2) Determine the mechanism by which loss of
NHE6 leads to aberrant endosome maturation, lysosomal function, and retrograde axonal transport; and 3)
Determine the extent to which impairments in neuronal connectivity in NHE6-null neurons are mediated by tau-
related mechanisms. In these Aims, we study mechanisms in CS, as well as neurodegenerative mechanisms
in the female-specific NHE6-related syndrome. This research will have a sustained impact on both
fundamental neuronal cell biology and on translational neuroscience. These studies will define the
neurodegenerative mechanisms in new genetic diseases in males and females, and will establish linkages with
more common neurodegenerative disorders, potentially identifying new therapeutic targets. Additionally, our
research uses a powerful integrated translational approach, bridging patient-oriented studies to experimental
models. Finally, we are establishing valuable experimental resources for these studies, which we will share
broadly in order to maximize their utility for the research community.
项目总结
人类遗传学为剖析神经退行性疾病的细胞机制提供了一种强有力的方法。我们
正在研究X连锁内体突变引起的神经变性的新遗传条件
Na+/H+交换器6(NHE6,也称为SLC9A6)。内溶酶系统功能障碍是一种常见的
是许多神经退行性疾病的特征。男性NHE6功能丧失突变导致克里斯汀病
综合征(CS),表现为神经发育和神经退行性混合病理。我的研究
该小组最近在女性NHE6突变携带者中发现了成人起病、神经退行性疾病。数据
在NHE6相关疾病支持病理学中,包括轴突变性、小脑变性和
弥漫性tau相关疾病。本R01提案中研究的目标是定义细胞
导致NHE6相关神经变性的机制,以及与其他
相关的神经退行性疾病,包括阿尔茨海默病(AD)和AD相关痴呆(ADRD)。
我们的中心假设是NHE6的丢失会导致晚期内小体的异常成熟,从而导致
异常逆行轴突运输和溶酶体功能障碍。我的研究小组和我们的合作者是
处于研究NHE6相关神经疾病的极佳位置,无论是男性还是女性,就像我们所做的那样
开发了独特的资源,包括:具有患者表型信息的国际患者登记;
小鼠NHE6条件突变;一组患者来源的具有强大控制的IPSC细胞;以及NHE6-空
大鼠模型。我们利用每个实验模型的相对优势来解决我们的科学
问题。我们将追求以下具体目标:1)证明神经元、细胞自主的丧失
NHE6在成熟大脑中的功能导致神经退化;2)决定了
NHE6导致内体异常成熟、溶酶体功能和逆行轴突运输;
确定tau-6在多大程度上介导了NHE6缺失神经元的神经元连接性损伤。
相关机制。在这些目标中,我们研究了CS的机制以及神经退行性机制
在女性特有的NHE6相关综合征中。这项研究将对这两个国家产生持续的影响
基础神经细胞生物学和翻译神经科学。这些研究将定义
男性和女性新遗传性疾病的神经退行性机制,并将与
更常见的神经退行性疾病,潜在地确定新的治疗靶点。此外,我们的
研究使用强大的综合翻译方法,将以患者为中心的研究与实验联系起来
模特们。最后,我们正在为这些研究建立有价值的实验资源,我们将分享这些资源
以最大限度地提高其对研究界的效用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Eric M Morrow其他文献
Postictal psychosis: presymptomatic risk factors and the need for further investigation of genetics and pharmacotherapy
- DOI:
10.1186/1744-859x-5-9 - 发表时间:
2006-07-21 - 期刊:
- 影响因子:3.100
- 作者:
Eric M Morrow;Jennifer M Lafayette;Edward B Bromfield;Gregory Fricchione - 通讯作者:
Gregory Fricchione
Eric M Morrow的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Eric M Morrow', 18)}}的其他基金
Mechanisms of Disease and Treatments in Novel Metabolic Development Brain Disorders
新型代谢发育脑疾病的疾病机制和治疗
- 批准号:
10622084 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
Mechanisms of disease and treatment in novel metabolic developmental brain disorders
新型代谢性发育性脑疾病的疾病机制和治疗
- 批准号:
10375639 - 财政年份:2021
- 资助金额:
$ 94.82万 - 项目类别:
Mechanisms of Disease and Treatment in Novel Metabolic Developmental Brain Disorders
新型代谢性发育性脑疾病的疾病机制和治疗
- 批准号:
10527375 - 财政年份:2021
- 资助金额:
$ 94.82万 - 项目类别:
Mechanisms of disease and treatment in novel metabolic developmental brain disorders
新型代谢性发育性脑疾病的疾病机制和治疗
- 批准号:
10712302 - 财政年份:2021
- 资助金额:
$ 94.82万 - 项目类别:
Mechanisms of Disease and Treatment in Novel Metabolic Developmental Brain Disorders
新型代谢性发育性脑疾病的疾病机制和治疗
- 批准号:
10745757 - 财政年份:2021
- 资助金额:
$ 94.82万 - 项目类别:
Neurodegenerative mechanisms in Christianson syndrome and NHE6-related disorders
Christianson 综合征和 NHE6 相关疾病的神经退行性机制
- 批准号:
9811045 - 财政年份:2019
- 资助金额:
$ 94.82万 - 项目类别:
Neurodegenerative Mechanisms in Christianson Syndrome and NHE6-Related Disorders
Christianson 综合征和 NHE6 相关疾病的神经退行性机制
- 批准号:
10417212 - 财政年份:2019
- 资助金额:
$ 94.82万 - 项目类别:
Neurodegenerative Mechanisms in Christianson Syndrome and NHE6-Related Disorders
Christianson 综合征和 NHE6 相关疾病的神经退行性机制
- 批准号:
10653694 - 财政年份:2019
- 资助金额:
$ 94.82万 - 项目类别:
Neurodegenerative Mechanisms in Christianson Syndrome and NHE6-Related Disorders
Christianson 综合征和 NHE6 相关疾病的神经退行性机制
- 批准号:
10213154 - 财政年份:2019
- 资助金额:
$ 94.82万 - 项目类别:
Neurodegenerative mechanisms in Christianson syndrome and NHE6-related disorders
Christianson 综合征和 NHE6 相关疾病的神经退行性机制
- 批准号:
10164658 - 财政年份:2019
- 资助金额:
$ 94.82万 - 项目类别:
相似海外基金
Investigating HDAC3 phosphorylation as an epigenetic regulator of memory formation in the adult and aging brain
研究 HDAC3 磷酸化作为成人和衰老大脑记忆形成的表观遗传调节剂
- 批准号:
10752404 - 财政年份:2023
- 资助金额:
$ 94.82万 - 项目类别:
The Health of Aging Parents of Adult Children with Serious Conditions
患有严重疾病的成年子女的年迈父母的健康
- 批准号:
10660046 - 财政年份:2023
- 资助金额:
$ 94.82万 - 项目类别:
Understanding Longer-Living Older Adult Research: The Summer Program on Aging
了解长寿老年人研究:老龄化夏季项目
- 批准号:
476343 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
Role of sensory experience in the regulation of plasticity in the developing, adult and aging brain
感官体验在发育、成人和衰老大脑可塑性调节中的作用
- 批准号:
RGPIN-2019-04761 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
Discovery Grants Program - Individual
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10365348 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
Adult Cognitive and Neurobiological Indicators of Aging: Impact of Adversity and Social Support
成人衰老的认知和神经生物学指标:逆境和社会支持的影响
- 批准号:
10700796 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10651861 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
Investigating the interface of epigenetics and metabolism underlying memory formation in the adult, aging, and AD brain
研究成人、衰老和 AD 大脑中记忆形成的表观遗传学和代谢界面
- 批准号:
10420533 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
Endogenous barcoding to determine complex dynamics of adult neurogenesis in aging and Alzheimer's disease
内源条形码确定衰老和阿尔茨海默病中成人神经发生的复杂动态
- 批准号:
10846200 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别:
THE DEVELOPMENT OF MECHANISM-BASED ADULT STEM CELL TREATMENTS TO COMBAT AGING PATHOLOGIES
开发基于机制的成人干细胞疗法来对抗衰老病理学
- 批准号:
10721544 - 财政年份:2022
- 资助金额:
$ 94.82万 - 项目类别: